COMP <GO>
SLB vs CVX // ALTMAN Z-SCORE & DEBT/EQUITY
SLB Limited (NYSE) VS. Chevron Corporation (NYSE) • 15-METRIC TALLY: SLB 7
— CVX 6
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: CVX
LAST: $53.74 (-0.13%) • MKT CAP: $79.43B
balance-sheet
3.19
LAST: $235.52 (+1.75%) • MKT CAP: $457.31B
balance-sheet
3.71
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SLB VS. CVX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SLB | CVX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.30% | -0.30 | CVX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.10% | 5.80% | +5.30 | SLB | /roic <GO> |
| EV/EBITDA & P/E Valuation | 14.9x | 21.5x | -6.60 | SLB | /valuation <GO> |
| Free Cash Flow Yield | 6.04% | 5.61% | +0.43 | SLB | /fcf-yield <GO> |
| Operating Margin | 11.50% | 8.10% | +3.40 | SLB | /operating-margins <GO> |
| Net Profit Margin | 9.40% | 6.70% | +2.70 | SLB | /net-margins <GO> |
| Revenue Growth (YoY) | -1.60% | -4.60% | +3.00 | SLB | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.02% | 2.79% | -0.77 | CVX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 3.19 | 3.71 | -0.52 | CVX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.10% | 7.10% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.5 | 72.8 | -11.38 | CVX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | 1.07 | -0.02 | CVX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.9x | 34.6x | -12.70 | SLB | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $79.43B | $457.31B | -$377.89B | CVX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SLB REV | CVX REV | SLB GROSS % | CVX GROSS % | SLB FCF | CVX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $35.71B | $184.43B | 44.0% | 41.3% | $4.79B | $25.64B |
| FY 2024 | $36.29B | $193.41B | 44.0% | 38.4% | $4.67B | $22.79B |
| FY 2023 | $33.13B | $196.91B | 44.0% | 44.0% | $5.15B | $26.75B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SLB // BETA 1.05
CVX // BETA 1.07